MeSH Browser

MeSH Heading: Doxazosin
Tree Number(s): D03.633.100.786.750.200
Unique ID: D017292
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D017292
Scope Note: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
Entry Term(s): 1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine; Alfamedin; Apo-Doxazosin; Cardular; Cardura; Carduran; Carduran Neo; Diblocin; Doxa-Puren; DoxaUro; Doxacor; Doxagamma; Doxamax; Doxatensa; Doxazomerck; Doxazosin AL; Doxazosin AZU; Doxazosin Apogepha; Doxazosin Heumann; Doxazosin Klast; Doxazosin Mesylate; Doxazosin Monohydrochloride; Doxazosin Stada; Doxazosin Von Ct; Doxazosin beta; Doxazosin findusFit; Doxazosin-Wolff; Doxazosin-ratiopharm; Doxazosina Alter; Doxazosina Cinfa; Doxazosina Combino Pharm; Doxazosina Geminis; Doxazosina Normon; Doxazosina Pharmagenus; Doxazosina Ratiopharm; Doxazosina Ur; Gen-Doxazosin; Jutalar; MTW-Doxazosin; Novo-Doxazosin; Progandol Neo; UK-33274; Uriduct; Zoxan; ratio-Doxazosin
Pharm Action: Antihypertensive Agents
Adrenergic alpha-1 Receptor Antagonists
Related Numbers: 70918-01-3; 74191-85-8; 77883-43-3; 86P6PQK0MU
CAS Type 1 Name: Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-
Previous Indexing: Prazosin/analogs & derivatives (1980-1992)
Public MeSH Note: 93; UK 33274 was indexed under PRAZOSIN/analogs & derivatives 1980-92
Online Note: use DOXAZOSIN (NM) to search UK 33274 1980-92
History Note: 93; was UK 33274 (NM) 1980-92
Date Established: 1993/01/01
Date of Entry: 1992/05/13
Revision Date: 2017/05/24

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, Fused-Ring [D03.633]
  - Heterocyclic Compounds, 2-Ring [D03.633.100]
    - Quinazolines [D03.633.100.786]
      - Prazosin [D03.633.100.786.750]
        
        Doxazosin [D03.633.100.786.750.200]

Doxazosin Preferred

Cardura Narrower

Concept UI: M0026252
Scope Note: Trade name in United States.
Terms: Cardura Preferred Term
Term UI T051613
Date01/29/1992
LexicalTag TRD
ThesaurusID; Zoxan
Term UI T615320
Date10/25/2004
LexicalTag TRD
ThesaurusID FR; Carduran
Term UI T051614
Date01/29/1992
LexicalTag TRD
ThesaurusID ES; Cardular
Term UI T615160
Date10/22/2004
LexicalTag TRD
ThesaurusID DE